|
Now accepting applications for the Aspire Summer Programs!
|
New Year, New You: Building Self-Confidence in 2017
|
By Leslie O'Brien, LICSW, Program Manager, Internship Program
A new year brings about reflection and optimism for a fresh start. Reflection often leads us to think back to experiences that did not go well. Mistakenly, we consider these past events as "failures." For young adults on the autism spectrum, these perceived failures can include: a poor interaction with a friend, an interview that didn't move forward, a family feud, misinterpreting a conversation with a colleague or supervisor, confusion about job responsibilities, a low grade on a test, tardiness to an important meeting, etc.
[Read More]
|
|
|
Hiding in Plain Sight:
Shining Light on Women with
Asperger/Autism Profiles
March 3, 2017
Newton Wellesley Hospital:
Bowles Conference Center
Are you a teen, adult, parent, or a professional in the field?
This timely conference, about girls and women with Asperger/Autism profiles, covers many topics pertinent to teens, adults, parents, and professionals in the field.
Preselected members of our community will read their first-person accounts. Topics include friendship, gender, late-life diagnosis, marriage, relationships, school, sensory, and work experiences. All attendees will receive a booklet of the first-person stories featured at the conference.
Attend in-person or view via the Live Stream.
|
BINA Farm Center Open House
|
Sunday, March 5, 2017
12:00-2:00 pm
55 Allen Street, Lexington, MA
We are excited to offer an intimate Open House to explore collaborative programming with BINA Farm Center (BFC) and Aspire for families who are interested in learning more about Therapeutic Riding, Horsemanship, Vocational Training and more!
Join Aspire Program Director, Dot Lucci, at a special BFC Open House for Aspire families! BFC Associate Director and PATH Int'l Certified Therapeutic Riding Instructor, Jenna Kaplan, and longtime Aspire and BINA parent, Dale McCarthy, will take you on a tour, introduce you to our herd, and provide information about BFC's programs.
|
|
|
Follow us on Instagram to learn more about our Child Services!
|
|
Research Opportunities
|
|
Lurie Center for Autism
The Lurie Center for Autism at Massachusetts General Hospital for Children is looking for participants for their currently enrolling studies!
For additional information about study requirements and study procedures, please contact Dr. Christopher McDougle's or
Dr. Ann Neumeyer's
study staff at 781-860-1711 or
LurieCenterResearch@partners.org.
-
Children's Autism Metabolome Project (CAMP) -
The Lurie Center is enrolling children ages 18 to 48 months who are in the process of getting evaluated for an autism spectrum disorder or developmental disorder, as well as typically developing children. This research study is being conducted to find out if a specific blood test is effective in the early detection of autism spectrum disorder. Participants are compensated for their time.
- Mirtazapine Treatment of Anxiety in Autism - The Lurie Center is conducting a study designed to evaluate the effects of mirtazapine in children with autistic disorder, Asperger's disorder or PDD not otherwise specified. Participants must be between the ages of 5 and 17 with difficulties with anxiety. Participants must have no significant medical illness and not have had a previous adequate trial of mirtazapine. Participants will receive study medication and all study related evaluations at no charge.
-
I
nvestigation of Neuroinflammation in Autism
- Seeking men aged 18-40 years with and without autism to participate in an investigation of the structure and function of the brain of adults with and without autism using MR-PET scans. Participants are compensated for their time.
The Bressler Clinical and Research Program
ASD Namenda Study Taking Place at MGH. Has your child ever been diagnosed with an autism spectrum disorder (ASD)? Does he or she have trouble communicating? Does he or she have problems reading social cues? Is your child 8-17 years old? Massachusetts General Hospital is conducting a research study using Namenda (memantine) to see if the medication has any effects on symptoms. The study also includes a brain scan before and after treatment to help us understand the functional and chemical characteristics of the brain in children and adolescents with ASD. 12 weeks of treatment with study medication or placebo-2 proton magnetic resonance spectroscopy scans of your child's brain Your child will receive monetary compensation for participating. If you are interested in learning about this research study at MGH, please call the study coordinator, Abby, at 617-724-7079.
|
|
|
|
|
| |
|
Apply
for the
Internship Program!
|
| About Aspire
Aspire is dedicated to providing children, teens, and adults with a high cognitive autism spectrum disorder or a related profile with the knowledge and skills necessary to make social connections and develop independence leading to successful and fulfilling lives.
MGH Aspire
1 Maguire Road
Lexington, MA 02421
p:781-860-1900
f: 781-860-1920
|
|
|
